2a:I[587520,["https://cdn.oninvest.com/_next/static/chunks/1f4dcf02c57c6a00.js","https://cdn.oninvest.com/_next/static/chunks/a282554578d34b69.js","https://cdn.oninvest.com/_next/static/chunks/7a2682d3e1f083e4.js","https://cdn.oninvest.com/_next/static/chunks/bbbaa3f15ad3f2c3.js","https://cdn.oninvest.com/_next/static/chunks/6b903eeab812db43.js","https://cdn.oninvest.com/_next/static/chunks/39d95a39efb58e1e.js","https://cdn.oninvest.com/_next/static/chunks/34c371605ae82ccf.js","https://cdn.oninvest.com/_next/static/chunks/ca19f4afd9a78812.js","https://cdn.oninvest.com/_next/static/chunks/37bb1d4dca622a2c.js","https://cdn.oninvest.com/_next/static/chunks/9fd7de3a0fcfc4f3.js","https://cdn.oninvest.com/_next/static/chunks/aba246ca02a566e3.js","https://cdn.oninvest.com/_next/static/chunks/62fb2cb73203c213.js"],"default"] 2c:I[27201,["https://cdn.oninvest.com/_next/static/chunks/d96012bcfc98706a.js","https://cdn.oninvest.com/_next/static/chunks/963c71eec1d89c3f.js"],"IconMark"] 2b:T4e1,Last week, Playboy’s pivot toward licensing and lingerie sales began to pay off, while AirSculpt highlighted a potential boost from growing demand for GLP-1-related plastic surgery. In biotech, AbCellera surged on successful trial results for its hot-flash drug, while Sionna cratered after its cystic fibrosis treatment failed in a mid-stage study. Meanwhile, financial services firm Marex Group reached an all-time high after market volatility helped drive a sharp rise in second-quarter revenue and net income. Oninvest recaps these stories from the small-cap space for the week of August 10-14.

Sionna Therapeutics, Inc. Stocks

In Guru Portfolios